¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(2ÀÏÂ÷) : 2022-04-30

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(2ÀÏÂ÷) : 2022-04-30
±³À°ÀÏÀÚ : 2022-04-30
±³À°Àå¼Ò : Conrad Hotel Seoul (5F PARK BALLROOM)  
±³À°ÁÖÁ¦ : 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ  
´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 02-2273-8556  
À̸ÞÀÏ : apcms@kscms.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í Á¶±â»çÀüµî·Ï/Á¤±Ô»çÀüµî·Ï/ÇöÀåµî·Ï(Foreign:50USD)(Domestic M.D. / Ph.D.:180,000/190,000/200,000 KRW)(Domestic Student/Nurse/Medical Representatives/Resident, etc.:30,000KRW)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-30 Room 1 09:00~09:20 Targeting Cardiovascular Inflammation: Next Steps in Clinical Translation  Paul Ridker(Harvard Univ. USA) 
±³À°½Ã°£ 04-30 Room 1 09:20~09:40 Lipoprotein(a): Cardiovascular Risk and Emerging Therapies.  Sotirios Tsimikas(Univ. of California San Diego USA) 
±³À°½Ã°£ 04-30 Room 1 09:40~10:00 Nitric Oxide and Cardiometabolic Function  Jeong A Kim(Univ. of Alabama at Birmingham USA) 
±³À°½Ã°£ 04-30 Room 1 10:00~10:20 Multiple benefits of GLP-1 receptor agonists cardiometabolic perspective  ÀÓ¼ö(¼­¿ïÀÇ´ë) 
Åä·Ð 04-30 Room 1 10:20~10:40 Discussion  ÃÖ¼ºÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 10:55~11:15 Omega-3 Fatty Acid - Pros  Deepak L. Bhatt(Harvard Univ. USA) 
±³À°½Ã°£ 04-30 Room 1 11:15~11:35 Omega-3 Fatty Acid- Cons  Stephen J. Nicholls(Monash Univ. Australia)) 
±³À°½Ã°£ 04-30 Room 1 11:35~11:45 Atrial Fibrillation Issue of Omega-3  ±è³²ÈÆ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 11:45~11:55 Mineral Oil: Safety and Use as Placebo in Clinical Studies  À念¿ì(°¡ÃµÀÇ´ë) 
Åä·Ð 04-30 Room 1 11:55~12:15 Discussion  ¼º±âö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 13:10~13:50 The Adiponectin Conundrum  °í±¤°ï(K-Heart Clinic & Lab) 
±³À°½Ã°£ 04-30 Room 1 14:00~14:15 Cardiologist¡¯s Perspective on Obesity  ±èÅÂÈÆ(Â÷ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 04-30 Room 1 14:15~14:30 Pharmacological Approach for Management of Obesity : Endocrinologist  Á¶À±°æ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 14:30~14:45 Debate PROS: Bariatric Surgery in Cardiovascular Disease- Is It Worth for Cardiovascular Outcome?  ¾È¼ö¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 14:45~15:00 Debate CONS: Bariatric Surgery in Cardiovascular Disease- Is It Worth for Cardiovascular Outcome?  ±è¹Ì°æ(°¡Å縯ÀÇ´ë) 
Åä·Ð 04-30 Room 1 15:00~15:15 Discussion  °ø¹Î±Ô(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 15:30~16:00 Aging, Arterial Stiffness, Cardiovascular Metabolism and Heart  Thomas Weber(Klinikum Wels-Grieskirchen Austria) 
±³À°½Ã°£ 04-30 Room 1 16:00~16:15 Increased Dipeptidyl Peptidase-4 Accelerates Diet-Related Vascular Aging and Atherosclerosis in Apoe-Deficient Mice Under Chronic Stress  Xian Wu Cheng(Yanbian Univ.China) 
±³À°½Ã°£ 04-30 Room 1 16:15~16:30 Aortic Stiffness Measurement in Cardiometabolic Syndrome  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 16:30~16:45 Carotid Ultrasound in Cardiometabolic Syndrome  ¼ÕÁ¤¿ì(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-30 Room 1 16:45~17:00 How to Properly Assess Coronary Calcification as a Consequence of Metabolic Syndrom  Masaaki Okutsu(New Tokyo Hosp. Japan) 
Åä·Ð 04-30 Room 1 17:00~17:15 Discussion  ±èÇüÀ±(Àü³²ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(2ÀÏÂ÷) : 2022-04-30""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°ñÀýÇÐȸ Á¦48Â÷ Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-30
´ÙÀ½±Û ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó 1ºÎ(1ÀÏÂ÷) : 2022-04-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 7 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 6 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 1 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 1 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 1 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 3 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 1 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷